A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer
Clinical trial NCT02448173 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT02448173
- Sponsor
- Vaccinogen Inc
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2031-08-01
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.